期刊文献+

RNA干扰环氧合酶2对人腰椎退变终板软骨细胞生长增殖及凋亡的影响 被引量:7

Effect of siRNA-Cox-2 on the growth inhibition and apoptosis of cartilage endplate chondrocytes
原文传递
导出
摘要 目的 观察沉默环氧合酶2(COX-2)基因对人腰椎退变软骨终板细胞增殖、凋亡的影响.方法 根据COX-2mRNA的序列,分别设计合成4对不同的且能干扰COX-2基因表达的siRNA并筛选出最高效抑制序列,构建以COX-2基因为靶点的RNA干扰质粒并将其转染腰椎退变软骨终板细胞.分为空白对照组(不予任何处理)、阴性对照siRNA组(30 nmol/L阴性siRNA)、siRNA1组(15 nmol/L COX-2 siRNA)和siRNA2组(30 nmol/L COX-2 siRNA).siRNA转染48 h后,采用荧光定量PCR法检测COX-2基因表达;WST-8检测细胞增殖情况;实时荧光定量聚合酶链反应(qPCR)法检测细胞凋亡相关基因survivin、bcl-x1、bax基因表达的情况.结果 构建的4组重组体插入片段的碱基序列完全正确.转染COX-2siRNA 48 h后人腰椎退变软骨细胞中COX-2mRNA表达量在siRNA1组和siRNA2组分别为(1.3±7.2)%和(35.4±3.6)%,均显著低于空白对照组(100±5.7)%和阴性对照组siRNA(83.4±2.8)%,P<0.05.免疫印迹实验显示COX-2蛋白表达量明显下降,以siRNA2组表达量最低(P<0.05=.WST-8法检测显示4组细胞存活率分别为(100.0±8.3)%、(84.9±4.2)%、(52.5±6.7)%、(48.9±5.4)%,siRNA1组和siRNA2组与其他各组相比,差异有统计学意义(P<0.05=.实时荧光定量聚合酶链反应(qPCR)检测显示,随着转染浓度的递增,退变软骨细胞中survivin、bcl-2基因表达较对照组显著降低,bax基因表达则较对照组逐渐升高.结论 RNA干扰COX-2基因能明显抑制人腰椎终板软骨细胞COX-2的表达,抑制细胞生长增殖,并可通过下调抗凋亡基因survivin和bcl-2的表达,上调促凋亡基因bax的表达,从而诱导退变软骨终板细胞凋亡. Objective To investigate the influence of siRNA-COX-2 gene upon the growth inhibition and apoptosis of cartilage endplate chondrocytes and provide new methods and evidence for siRNA in gene therapy of cartilage endplate chondrocytes. Methods According to the sequence of COX-2 mRNA,COX-2 siRNA was designed, synthesized, cloned into the GFP reporter pcDNA6. 2GW/EmGFPmiR vector and transfected into Hep cell line. The integrity of inset fragment was detected by colony PCR ( polymerase chain reaction) and sequencing analysis. The cultured cartilage endplate chondrocytes were divided into 4 groups: control group (untreated), negative siRNA group (treatment with 30 nmol/L negative control siRNA), siRNA1 group (treatment with 15 nmol/L COX-2 siRNA) and siRNA2 group (treatment with 30 nmol/L COX-2 siRNA). The biological activity of recombinants was identified with the interference efficiency of COX-2 siRNA recombinant by real-time PCR and Western blot. And the effects of COX-2 inhibitor on the growth of chondrocytes were detected by WST-8 and the mRNA expressions of survivin, bcl-2 and bax genes measured by real-time PCR. Results The sequences of inset fragment in 4 siRNA expressing recombinants were correct After COX-2 transfection, the expression of COX-2 mRNA in chondrocytes was 51.3% ±7. 2%in the siRNA1 group and 35.4% ±3.6% in the siRNA2 group. Western blot showed that the expression of COX-2 protein decreased, especially in siRNA2 group (P < 0.05 ). And the cell survival rate was 100.0% ±8.3% in the control group, 84.9% ±4.2% in the negative control siRNA group, 52.5% ±6. 7% in the siRNA1 group and 48.9% ± 5.4% in the siRNA2 group ( P < 0. 05 ). Meanwhile, the expressions of mRNA of survivin and bcl-2 decreased while the expression of bax mRNA increased in degenerative cartilage endplate chondrocytes transfected with COX-2 siRNA ( P < 0. 05 ). Conclusion COX-2-targeting siRNA inhibits the expression of COX-2, suppresses the proliferation of chondrocytes and induces the cell apoptosis. These effects may be attributable to the up-regulation of survivin and bcl-2 and the downregulation of bax.
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第15期1031-1035,共5页 National Medical Journal of China
基金 上海交通大学医学院科技发展基金(09XJ21048) 上海市卫生局青年科技项目(2009Y037)
关键词 关节疾病 软骨细胞 软骨 Joint diseases Chondrocytes Cartilage
  • 相关文献

参考文献11

  • 1de Boer TN,Huisman AM,Polak AA,et al.The chondroprotective effect of selective COX-2 inhibition in osteoarthritis:ex vivo evaluation of human cartilage tissue after in vivo treatment.Osteoarthritis and Cartilage,2009,17:482-488.
  • 2Ross JS,Carlson J A,Brock G.miRNA:the new gene silencer.Am J ClinPathol,2007,128:830-836.
  • 3Jeffrey JE,Aspden RM.Cyclooxygenase inhibition lowers prostaglandin E2 release from articular cartilage and reduces apoptosis but not proteoglycan degradation following an impact load in vitro.Arthritis Res Ther,2007,9:129.
  • 4Mastbergen SC,Bijlsma JW,Lafeber FP.Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage:a human in vitro study.Osteoarthritis Cartilage,2005,13:519-526.
  • 5Nah SS,Won HJ,Ha E,et al.Epidermal growth factor increases prostaglandin E2 production via ERK1/2 MAPK and NF-kappaB pathway in fibroblast like synoviocytes from patients with rheumatoid arthritis.Rheumatol Int,2010,30:443-449.
  • 6Mastbergen SC,Jansen NW,Johannes W.Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage:an invitro study.Arthritis Res Therapy,2006,8:2.
  • 7Moore CB,Guthrie EH,Huang MT,et al.Short hairpin RNA (shRNA):design,delivery,and assessment of gene knockdown.Methods Mol Biol,2010,6:141-158.
  • 8程文,苏筠,马宏青,位志峰,高建平,张征宇,葛京平,景抗震,徐锋.联合RNA干扰TR及TERT对膀胱移行细胞癌BIU-87细胞株端粒酶活性及其增殖的影响[J].中华医学杂志,2009,89(40):2847-2852. 被引量:4
  • 9Elbashir SM,Harborth J,Weber K,et al.Analysis of gene function in somatic mammalian cells using small interfering RNAs.Methods,2002,26:199-213.
  • 10Racz B,Reglodi D,Fodor B,et al.Hyperosmotic stressinduced apoptotic signaling pathways in chondrocytes.Bone,2007,40:1536-1543.

二级参考文献12

  • 1Nakatsukasa H,Onishi T,Kaneyoshi T,et al.Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatceelhlar carcinoma.Br J Cancer,2000,82:833-837.
  • 2Lord RV,Salonga D,Danenberg KD,et al.Telomerase revease transeriptase expression is increased early in the Barrett's metaplasia,dysplasia,adenocarcinoma sequence,J Gastrointast Stag,2000,4:135-142.
  • 3Kanagi Y,Kabayashi D,Yajima T,et al.Telomerase activity is down regulated via decreases in hTERT but not TEP1 mRNA or hTERC during the differentiation of leukemic cells.Anticaacer Ras,21300,20:773-778.
  • 4Rhya MS.Telomeres telomerase and immortality.J Natl Cancer Inat,1995,87:884.
  • 5Zou L,Zhang P,Luo C,et al.shRNA,targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity.Cancer Chemother Pharmscol,2005,19:1-7.
  • 6Ito H,Kyo S,Kanaya T,et al.Expression of human telomerase subunit and correlation with telomerase activity in urothelial cancer.CAin Cancer Res,1998,4:1803-1808.
  • 7Lancehn F,Anidjar M,Vilhtte JM,et al.Telomerase activity as a potential marker in preneoplastic bladder lesions.BJU hat,2000,85:526-531.
  • 8Suzuki T,Suziki Y,Fujioka T,et al.Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer.J Uro1,1999,162:2217-2220.
  • 9Glasgow JN,Everts M,Curid DT.Transductional targeting of adenoviras vectors for gene therapy.Cancer Gene Ther,2006,13:830-844.
  • 10Elbashir SM,Lendeckel W,Tuschl T.RNA interference is mediated by 21-and 22-nucleotide RNAs.Gene Dev,2001,15:188-200.

共引文献3

同被引文献49

  • 1赵倩.针灸治疗腰椎间盘突出症的方法探讨[J].现代中医药,2007,27(1):60-61. 被引量:17
  • 2骨关节炎诊治指南(2007年版)[J].中华骨科杂志,2007,27(10):793-796. 被引量:2029
  • 3Ota H,Igarashi S,Sasaki M,et al.Distribution of cyclooxygenase-2in eutopic and ectopic endometrium in endometriosis and adenomyosis[J].Hum Reprod,2001,16(3):561-566.
  • 4Li Y,Zou S,Xia X,et al.Human adenomyosis endometrium stromal cells secreting more nerve growth factor:impact and effect[J].Reprod Sci,2015,22(9):1073-1082.
  • 5Chen YJ,Li HY,Huang CH,et al.Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis[J].J Pathol,2010,222(3):261-270.
  • 6Weimar CH,Macklon NS,Post Uiterweer ED,et al.The motile and invasive capacity of human endometrial stromal cells:implications for normal and impaired reproductive function[J].Hum Reprod Update,2013,19(5):542-557.
  • 7Benagiano G,Brosens I.The endometrium in adenomyosis[J].Womens Health(Lond Engl),2012,8(3):301-312.
  • 8Chen YJ,Li HY,Chang YL,et al.Suppression of migratory/invasive ability and induction of apoptosis in adenomyosisderived mesenchymal stem cells by cyclooxygenase-2inhibitors[J].Fertil Steril,2010,94(6):1972-1979,1979.e1-1979.e4.
  • 9Huang TS,Chen YJ,Chou TY,et al.Oestrogen-induced angiogenesis promotes adenomyosis by activating the SlugVEGF axis in endometrial epithelial cells[J].J Cell Mol Med,2014,18(7):1358-1371.
  • 10Li T,Li YG,Pu DM.Matrix metalloproteinase-2and-9expression correlated with angiogenesis in human adenomyosis[J].Gynecol Obstet Invest,2006,62(4):229-235.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部